Keywords: fda, orders, label, safety, warnings, echocardiogram, imaging

FDA orders label safety warnings for echocardiogram imaging agents

Article | 15 October 2007

Print This

The US Food and Drug Administration has received reports of cardiac problems and mortalities in patients subjected to Bristol-Myers Squibb's ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in